Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of POR*28 and CYP3A5 polymorphisms on tacrolimus trough concentration/dose ratio in Thai kidney transplant recipients
TCTR20170227005Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Mar 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Ramathibodi Hospital. Started Mar 2017; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on TCTR20170227005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170227005.